Assembly Biosciences, Inc. (ASMB) vs Eikon Therapeutics, Inc. Common Stock (EIKN)

A side-by-side comparison of Assembly Biosciences, Inc. and Eikon Therapeutics, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Assembly Biosciences, Inc. logo
ASMB
Assembly Biosciences, Inc.
$442M
$22.28HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
Eikon Therapeutics, Inc. Common Stock logo
EIKN
Eikon Therapeutics, Inc. Common Stock
$420M
$7.75HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT

Total return — ASMB vs EIKN

growth of $100 · dividends reinvested · last 1y
ASMB -15.9% (-15.9%/yr)EIKN -49.7% (-49.7%/yr)ASMB compounded faster over this window
6080100120Start $100$84$50
ASMB EIKN

ASMB vs EIKN: by the numbers

  • •ASMB is the larger company ($442M vs $420M market cap).

Metrics side by side

Valuation

MetricASMBEIKN
P/E ratio40.51N/A
P/S ratio5.90N/A
P/B ratio1.440.90

Profitability

MetricASMBEIKN
Gross margin99.82%0.00%
Operating margin-11.75%0.00%
Net margin-0.06%0.00%
ROE-0.01%-69.06%
ROIC-2.86%-46.16%

Growth (annualized)

MetricASMBEIKN
Revenue CAGR (5Y)-1.78%N/A
Total return CAGR (5Y)-10.66%N/A

Go deeper

Full ASMB analysisFull EIKN analysisInteractive comparison tool

Dig into the metrics

Assembly Biosciences P/E ratioAssembly Biosciences ROEEikon Therapeutics, Inc. Common Stock ROEAssembly Biosciences operating marginEikon Therapeutics, Inc. Common Stock operating marginAssembly Biosciences revenue growthEikon Therapeutics, Inc. Common Stock revenue growthAssembly Biosciences free cash flowEikon Therapeutics, Inc. Common Stock free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.